Bin Yan
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 13
- NF-κB Signaling Pathways 8
- MicroRNA in disease regulation 8
- Molecular Biology top 2%
- RNA modifications and cancer 13
- RNA Interference and Gene Delivery 10
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 10
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 9
- Immunology top 5%
- Geriatrics and Gerontology top 5%
- Co-authors
- Yongguang TaoChuan‐Yuan LiLiang ChengQingyong MaYa CaoMark W. DewhirstWeikun QianYongyong Shi
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Bin Yan
158 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.5k
- Molecular Biology 2.8k
- Oncology 899
- Immunology 692
- Geriatrics and Gerontology 119
Countries citing papers authored by Bin Yan
This map shows the geographic impact of Bin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Yan more than expected).
Fields of papers citing papers by Bin Yan
This network shows the impact of papers produced by Bin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Yan. The network helps show where Bin Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 15 | |
| 9 | 2022 | 27 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 155 | |
| 13 | 2019 | 0 | |
| 14 | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53breakdown → | 2018 | 402 |
| 15 | 2018 | 69 | |
| 16 | 2018 | 61 | |
| 17 | 2017 | 3 | |
| 18 | 2014 | 23 | |
| 19 | 2006 | 131 | |
| 20 | Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. | 2003 | 30 |
About Bin Yan
Bin Yan is a scholar working on Cancer Research, Immunology and Oncology, having authored 179 papers that have together received 4.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers), RNA Interference and Gene Delivery (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Cancer-related Molecular Pathways (9 papers), Cancer Cells and Metastasis (9 papers), NF-κB Signaling Pathways (8 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (2.8k citations) and Oncology (899 citations). Bin Yan has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Yongguang Tao, Chuan‐Yuan Li, Liang Cheng, Qingyong Ma, Ya Cao, Mark W. Dewhirst, Weikun Qian, Yongyong Shi, Yiqun Jiang and Junyu Cao. Their work appears in journals such as Scientific Reports, Cancers, Cancer Research, Annals of Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.